Skip to Content
Rank 2126
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address PAUL-EHRLICH-STRABE 15 TUBINGEN, BADEN-WURTTEMBERG, DE

Curevac - Key figures

Market cap 2.61 Billion
Revenue 117.33 Million
Profit -135,086,000
P/E Ratio No information
P/s Ratio 22.23
Buy $CVAC at eToro

Curevac - Description

CureVac NV, a clinical-stage biopharmaceutical company, is focused on developing various transformative drugs based on messenger ribonucleic acid (mRNA).

The company is headquartered in Tbingen, Germany.